SFGate | Valeant: We’ll bump Allergan offer to $200 a share SFGate The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox. The letter to Allergan’s board Monday did not break down the exact terms of … Valeant willing to raise offer for Botox maker AllerganFinancial Times Dealpolitik: Path to Nowhere in Allergan Litigation?Wall Street Journal (blog) Valeant will increase bid for botox maker Allergan to $200 per shareThe Guardian Los Angeles Times -TheStreet.com -Fortune all 185 news articles » |
Valeant: We'll bump Allergan offer to $200 a share - SFGate
No comments:
Post a Comment